Volgende

Automatisch afspelen

MARS: mutation-adjusted risk score for advanced systemic mastocytosis

1 Bekeken • 07/09/23
Delen
insluiten
administrator
administrator
abonnees
0

Andreas Reiter, MD, University Medical Centre, Mannheim, Germany, discusses how a mutation-adjusted risk score (MARS) may improve treatment stratification for advanced systemic mastocytosis (AdvSM). This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.

Laat meer zien
0 Comments sort Sorteer op
Facebook Reacties

Volgende

Automatisch afspelen